Polycystic ovary syndrome. E28.2
Conditions
Interventions
Intervention 1: Control group: Patients referring to Akbar Abadi Hospital who are willing to cooperate and have inclusion criteria will recieve starch. They will use 3 gram Starch from Golha factory
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: Patients with Polycystic ovary Syndrome based on two criteria of the three diagnostic criteria of the disease based on Rotterdam: 1.Bleeding is reduced or discontinued (as Delay more than 35 days or less than 8 bleeding episodes per year) 2. Clinical symptoms including hirsutism or Ferriman-Gallway (MGF) score above 8, acne and male pattern baldness and biochemical symptoms of increased androgenesis. 3. Polycystic ovary (12 or more of 12 follicles per ovary with a diameter of 2 to 9 mm, or an increase in ovarian volume to more than 310 ml). Patients with age between 20 to 40 years old. patient's acceptance of taking part in the study.
Exclusion criteria
Exclusion criteria: Those who take drugs of anticoagulants and hyperlipidemia Use Tobacco Having kidney disease, diabetes, liver disease, cardiovascular disorders, hypothyroidism, inflammatory and rheumatic diseases, hyperprolactinemia, Cushing's syndrome, and congenital adrenal hyperplasia Follow a particular diet in the last three months. Take medications that affect insulin sensitivity, inflammation, or lipid profile and hormonal profile, including glucocorticoid drugs, ovulation induction drugs, anti-obesity, anti-diabetes, antihypertensive, estrogenic, anti-androgen, over the past 3 months Unwilling to participate in the study Use of Nutrition Supplements in the last 2 months Pregnancy or breastfeeding Sensitization or allergy to sumac
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum malondialdehyde. Timepoint: Before intervention and 3 months after intervention. Method of measurement: colorimetric method.;Glutathione peroxidase. Timepoint: Before intervention and 3 months after intervention. Method of measurement: colorimetric method.;Superoxide dismutase. Timepoint: Before intervention and 3 months after intervention. Method of measurement: colorimetric method.;Total antioxidant capacity. Timepoint: Before intervention and 3 months after intervention. Method of measurement: elisa method.;Uric acid. Timepoint: Before intervention and 3 months after intervention. Method of measurement: turbiditymetery method. | — |
Secondary
| Measure | Time frame |
|---|---|
| Dietry intake. Timepoint: Before intervention and 3 months after intervention. Method of measurement: 24-hour questionnaire food intake for 3 days and analysis with N4 software.;Anthropometric indices. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Meters, scales and computing.;Physical activity. Timepoint: Before intervention and 3 months after intervention. Method of measurement: International Physical Activity Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Naheed Aryaeian
Iran University of Medical Sciences
Outcome results
None listed